NASDAQ OMX welcomes Dignitana to First North

Stockholm, December 1, 2011 — NASDAQ OMX (NASDAQ: NDAQ) announces that trading in Dignitana AB (short name: DIGN) shares will commence today, December 1, on First North at NASDAQ OMX Stockholm. Dignitana belongs to the Health Care sector and is the 14th company to be admitted to trading on First North in 2011, and the fifth company this year to move its listing from Aktietorget to First North.

Founded in Lund, Sweden in 2000, Dignitana’s business concept is to develop, manufacture and market a medical device primarily used for scalp cooling, to eliminate or greatly reduce chemotherapy induced hair loss. The DigniCap™system is patented in Europe, Japan and the USA and has been used by thousands of patients. For more information, visit www.dignitania.se.

Jenny Rosberg, Senior Vice President at NASDAQ OMX said, “We are very pleased that Dignitana chose to list at First North, one of Europe’s most liquid marketplaces for growth companies. We’ve experience a marked inflow of healthcare companies to First North, and Dignitana is our fifth addition to the healthcare sector this year”.

Dignitana has appointed Erik Penser Bankaktiebolag as Certified Adviser

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.

NASDAQ OMX Media contact: 

Carl Norell +46 (8) 405 66 39

carl.norell@nasdaqomx.com

In This Story